US 11834507
Anti-MET agonist antibody for use in the treatment of colorectal cancer
granted A61KA61K2039/505A61P
Quick answer
US patent 11834507 (Anti-MET agonist antibody for use in the treatment of colorectal cancer) held by AGOMAB THERAPEUTICS expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AGOMAB THERAPEUTICS
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00